{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:07:53Z","timestamp":1793725673035,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["8177225"],"award-info":[{"award-number":["8177225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81971969"],"award-info":[{"award-number":["81971969"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The main symptoms of schistosomiasis are granuloma and fibrosis, caused by<jats:italic>Schistosoma<\/jats:italic>eggs. Numerous types of cells and cytokines are involved in the progression of<jats:italic>Schistosoma<\/jats:italic>infection. As a class of innate immune cells, \u03b3\u03b4 T cells play critical roles in the early immune response. However, their role in modulating granuloma and fibrosis remains to be clarified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Liver fibrosis in wild-type (WT) mice and T cell receptor (TCR) \u03b4 knockout (KO) mice infected with<jats:italic>Schistosoma japonicum<\/jats:italic>was examined<jats:italic>via<\/jats:italic>Masson\u2019s trichrome staining of collagen deposition and quantitative reverse transcriptase-PCR (RT-PCR) of fibrosis-related genes. Granuloma was detected by hematoxylin-eosin (H&amp;E) staining and quantified. Flow cytometry was used for immune cell profiling and for detecting cytokine secretion. The abundance of the related cytokines was measured using quantitative RT-PCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The livers of<jats:italic>S. japonicum<\/jats:italic>-infected mice had significantly increased proportions of interleukin (IL)-17A producing \u03b3\u03b4 T cells and secreted IL-17A. Compared with the WT mice, TCR \u03b4 deficiency resulted in reduced pathological impairment and fibrosis in the liver and increased survival in infected mice. In addition, the profibrogenic effects of \u03b3\u03b4 T cells in infected mice were associated with enhanced CD11b<jats:sup>+<\/jats:sup>Gr-1<jats:sup>+<\/jats:sup>cells, concurrent with increased expression of transforming growth factor (TGF)-\u03b2 in the liver.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this mouse model of<jats:italic>Schistosoma<\/jats:italic>infection, \u03b3\u03b4 T cells may promote liver fibrosis by recruiting CD11b<jats:sup>+<\/jats:sup>Gr-1<jats:sup>+<\/jats:sup>cells. These findings shed new light on the pathogenesis of liver pathology in murine schistosomiasis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13071-020-04200-4","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T07:53:05Z","timestamp":1593589985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["IL-17A-producing \u03b3\u03b4 T cells promote liver pathology in acute murine schistosomiasis"],"prefix":"10.1186","volume":"13","author":[{"given":"Lei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenci","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina Tuwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"4200_CR1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1056\/NEJMra012396","volume":"346","author":"AG Ross","year":"2002","unstructured":"Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, et al. Schistosomiasis. N Engl J Med. 2002;346:1212\u201320.","journal-title":"N Engl J Med."},{"key":"4200_CR2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","volume":"368","author":"B Gryseels","year":"2006","unstructured":"Gryseels B, Polman K, Clerinx J. Kestens. Human schistosomiasis. Lancet. 2006;368:1106\u201318.","journal-title":"Lancet"},{"key":"4200_CR3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.idc.2012.03.004","volume":"26","author":"B Gryseels","year":"2012","unstructured":"Gryseels B. Schistosomiasis. Infect Dis Clin North Am. 2012;26:383\u201397.","journal-title":"Infect Dis Clin North Am."},{"key":"4200_CR4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri843","volume":"2","author":"EJ Pearce","year":"2002","unstructured":"Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol. 2002;2:499\u2013511.","journal-title":"Nat Rev Immunol."},{"key":"4200_CR5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1172\/JCI7325","volume":"104","author":"MG Chiaramonte","year":"1999","unstructured":"Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest. 1999;104:777\u201385.","journal-title":"J Clin Invest."},{"key":"4200_CR6","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4049\/jimmunol.164.5.2585","volume":"164","author":"PG Fallon","year":"2000","unstructured":"Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol. 2000;164:2585\u201391.","journal-title":"J Immunol."},{"key":"4200_CR7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.189.10.1565","volume":"189","author":"GJ McKenzie","year":"1999","unstructured":"McKenzie GJ, Fallon PG, Emson CL, Grencis RK, McKenzie AN. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med. 1999;189:1565\u201372.","journal-title":"J Exp Med."},{"key":"4200_CR8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn TA. Fibrotic disease and the T(H)1\/T(H)2 paradigm. Nat Rev Immunol. 2004;4:583\u201394.","journal-title":"Nat Rev Immunol."},{"key":"4200_CR9","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.3389\/fimmu.2018.02781","volume":"9","author":"SD Kamdem","year":"2018","unstructured":"Kamdem SD, Moyou-Somo R, Brombacher F, Nono JK. Host regulators of liver fibrosis during human schistosomiasis. Front Immunol. 2018;9:2781.","journal-title":"Front Immunol."},{"key":"4200_CR10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","volume":"21","author":"JK Kolls","year":"2004","unstructured":"Kolls JK, Lind\u00e9n A. Interleukin-17 family members and inflammation. Immunity. 2004;21:467\u201376.","journal-title":"Immunity."},{"key":"4200_CR11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","volume":"9","author":"SL Gaffen","year":"2009","unstructured":"Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev. Immunol. 2009;9:556\u201367.","journal-title":"Nat Rev. Immunol."},{"key":"4200_CR12","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.cellsig.2010.11.022","volume":"23","author":"SH Chang","year":"2011","unstructured":"Chang SH, Dong C. Signaling of interleukin-17 family cytokines in immunity and inflammation. Cell Signal. 2011;23:1069\u201375.","journal-title":"Cell Signal."},{"key":"4200_CR13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/cmi.2010.5","volume":"7","author":"F Lafdil","year":"2010","unstructured":"Lafdil F, Miller AM, Ki SH, Gao B. Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol. 2010;7:250\u20134.","journal-title":"Cell Mol Immunol."},{"key":"4200_CR14","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl. J Med. 2009;361:888\u201398.","journal-title":"N Engl. J Med."},{"key":"4200_CR15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.it.2011.08.003","volume":"32","author":"CM Wilke","year":"2011","unstructured":"Wilke CM, Bishop K, Fox D, Zou W. Deciphering the role of Th17 cells in human disease. Trends Immunol. 2011;32:603\u201311.","journal-title":"Trends Immunol."},{"key":"4200_CR16","doi-asserted-by":"crossref","first-page":"e1313369","DOI":"10.1080\/2162402X.2017.1313369","volume":"6","author":"X Sun","year":"2017","unstructured":"Sun X, Cai Y, Fleming C, Tong Z, Wang Z, Ding C, et al. Innate \u03b3\u03b4 T17 cells play a protective role in DSS-induced colitis via recruitment of Gr-1+ CD11b+ myeloid suppressor cells. Oncoimmunology. 2017;6:e1313369.","journal-title":"Oncoimmunology."},{"key":"4200_CR17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","volume":"13","author":"L Steinman","year":"2007","unstructured":"Steinman L. A brief history of T(H)17, the first major revision in the T(H)1\/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007;13:139\u201345.","journal-title":"Nat Med."},{"key":"4200_CR18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","volume":"25","author":"A Bendelac","year":"2007","unstructured":"Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol. 2007;25:297\u2013336.","journal-title":"Annu Rev Immunol."},{"issue":"148\u201358","key":"4200_CR19","first-page":"e5","volume":"47","author":"AJ St Leger","year":"2017","unstructured":"St Leger AJ, Desai JV, Drummond RA, Kugadas A, Almaghrabi F, Silver P, et al. An ocular commensal protects against corneal infection by driving an interleukin-17 response from mucosal \u03b3\u03b4 T cells. Immunity. 2017;47(148\u201358):e5.","journal-title":"Immunity."},{"key":"4200_CR20","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.4049\/jimmunol.1101445","volume":"187","author":"MG Shainheit","year":"2011","unstructured":"Shainheit MG, Lasocki KW, Finger E, Larkin BM, Smith PM, Sharpe AH, et al. The pathogenic Th17 cell response to major schistosome egg antigen is sequentially dependent on IL-23 and IL-1beta. J Immunol. 2011;187:5328\u201335.","journal-title":"J Immunol."},{"key":"4200_CR21","doi-asserted-by":"crossref","first-page":"e1399","DOI":"10.1371\/journal.pntd.0001399","volume":"5","author":"X Wen","year":"2011","unstructured":"Wen X, He L, Chi Y, Zhou S, Hoellwarth J, Zhang C, et al. Dynamics of Th17 cells and their role in Schistosoma japonicum infection in C57BL\/6 mice. PLoS Negl Trop Dis. 2011;5:e1399.","journal-title":"PLoS Negl Trop Dis."},{"key":"4200_CR22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/imm.12105","volume":"139","author":"D Chen","year":"2013","unstructured":"Chen D, Luo X, Xie H, Gao Z, Fang H, Huang J. Characteristics of IL-17 induction by Schistosoma japonicum infection in C57BL\/6 mouse liver. Immunology. 2013;139:523\u201332.","journal-title":"Immunology."},{"key":"4200_CR23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/intimm\/dxv017","volume":"27","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Huang D, Gao W, Yan J, Zhou W, Hou X, et al. Lack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica. Int Immunol. 2015;27:317\u201325.","journal-title":"Int Immunol."},{"key":"4200_CR24","doi-asserted-by":"crossref","first-page":"e1004097","DOI":"10.1371\/journal.ppat.1004097","volume":"10","author":"X Chen","year":"2014","unstructured":"Chen X, Yang X, Li Y, Zhu J, Zhou S, Xu Z, et al. Follicular helper T cells promote liver pathology in mice during Schistosoma japonicum infection. PLoS Pathog. 2014;10:e1004097.","journal-title":"PLoS Pathog."},{"key":"4200_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00436-017-5678-5","volume":"117","author":"A Farwa","year":"2018","unstructured":"Farwa A, He C, Xia L, Zhou H. Immune modulation of Th1, Th2, and T-reg transcriptional factors differing from cytokine levels in Schistosoma japonicum infection. Parasitol Res. 2018;117:115\u201326.","journal-title":"Parasitol Res."},{"key":"4200_CR26","doi-asserted-by":"crossref","first-page":"e0004306","DOI":"10.1371\/journal.pntd.0004306","volume":"10","author":"A Romano","year":"2016","unstructured":"Romano A, Hou X, Sertorio M, Dessein H, Cabantous S, Oliveira P, et al. FOXP3+ regulatory T cells in hepatic fibrosis and splenomegaly caused by Schistosoma japonicum: the spleen may be a major source of Tregs in subjects with splenomegaly. PLoS Negl Trop Dis. 2016;10:e0004306.","journal-title":"PLoS Negl Trop Dis."},{"key":"4200_CR27","doi-asserted-by":"crossref","first-page":"e0007000","DOI":"10.1371\/journal.pntd.0007000","volume":"12","author":"W Gong","year":"2018","unstructured":"Gong W, Huang F, Sun L, Yu A, Zhang X, Xu Y, et al. Toll-like receptor-2 regulates macrophage polarization induced by excretory-secretory antigens from Schistosoma japonicum eggs and promotes liver pathology in murine schistosomiasis. PLoS Negl Trop Dis. 2018;12:e0007000.","journal-title":"PLoS Negl Trop Dis."},{"key":"4200_CR28","doi-asserted-by":"crossref","first-page":"e12528","DOI":"10.1111\/pim.12528","volume":"40","author":"L Xu","year":"2018","unstructured":"Xu L, Xue B, Zhou L, Qiu Z, Zhang X, Xu N, et al. NP 30 stimulates Th17 differentiation through DC in schistosomiasis japonicum. Parasite Immunol. 2018;40:e12528.","journal-title":"Parasite Immunol."},{"key":"4200_CR29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1146\/annurev.immunol.18.1.975","volume":"18","author":"AC Hayday","year":"2000","unstructured":"Hayday AC. \u03b3\u03b4 cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol. 2000;18:975\u20131026.","journal-title":"Annu Rev Immunol."},{"key":"4200_CR30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","volume":"32","author":"Y Chien","year":"2014","unstructured":"Chien Y, Meyer C, Bonneville M. \u03b3\u03b4 T cells: first line of defense and beyond. Annu Rev Immunol. 2014;32:121\u201355.","journal-title":"Annu Rev Immunol."},{"key":"4200_CR31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1189\/jlb.3RU0914-443R","volume":"97","author":"S Paul","year":"2015","unstructured":"Paul S, Lal G. Role of gamma-delta (\u03b3\u03b4) T cells in autoimmunity. J Leukoc Biol. 2015;97:259\u201371.","journal-title":"J Leukoc Biol."},{"key":"4200_CR32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nri3904","volume":"15","author":"B Silva-Santos","year":"2015","unstructured":"Silva-Santos B, Serre K, Norell H. \u03b3\u03b4 T cells in cancer. Nat Rev Immunol. 2015;15:683\u201391.","journal-title":"Nat Rev Immunol."},{"key":"4200_CR33","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ni.3726","volume":"18","author":"PH Papotto","year":"2017","unstructured":"Papotto PH, Ribot JC, Silva-Santos B. IL-17+ \u03b3\u03b4 T cells as kick-starters of inflammation. Nat Immunol. 2017;18:604\u201311.","journal-title":"Nat Immunol."},{"key":"4200_CR34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/imm.12993","volume":"155","author":"A Akitsu","year":"2018","unstructured":"Akitsu A, Iwakura Y. Interleukin-17-producing \u03b3\u03b4 T (\u03b3\u03b417) cells in inflammatory diseases. Immunology. 2018;155:418\u201326.","journal-title":"Immunology."},{"key":"4200_CR35","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00018-018-2788-x","volume":"75","author":"C Peters","year":"2018","unstructured":"Peters C, Kabelitz D, Wesch D. Regulatory functions of \u03b3\u03b4 T cells. Cell Mol Life Sci. 2018;75:2125\u201335.","journal-title":"Cell Mol Life Sci."},{"key":"4200_CR36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11684-017-0584-x","volume":"12","author":"X Wang","year":"2018","unstructured":"Wang X, Tian Z. \u03b3\u03b4 T cells in liver diseases. Front Med. 2018;12:262\u20138.","journal-title":"Front Med."},{"key":"4200_CR37","doi-asserted-by":"crossref","first-page":"e01020","DOI":"10.1128\/IAI.01020-16","volume":"85","author":"L Zheng","year":"2017","unstructured":"Zheng L, Hu Y, Wang Y, Huang X, Xu Y, Shen Y, et al. Recruitment of neutrophils mediated by V\u03b32 \u03b3\u03b4 T cells deteriorates liver fibrosis induced by Schistosoma japonicum infection in C57BL\/6 mice. Infect Immun. 2017;85:e01020\u2013116.","journal-title":"Infect Immun."},{"key":"4200_CR38","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4049\/jimmunol.162.2.920","volume":"162","author":"MG Chiaramonte","year":"1999","unstructured":"Chiaramonte MG, Schopf LR, Neben TY, Cheever AW, Donaldson DD, Wynn TA. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J Immunol. 1999;162:920\u201330.","journal-title":"J Immunol."},{"key":"4200_CR39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm1332","volume":"12","author":"S Fichtner-Feigl","year":"2005","unstructured":"Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med. 2005;12:99\u2013106.","journal-title":"Nat Med."},{"key":"4200_CR40","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2174\/1389450116666150531153627","volume":"16","author":"DA Giles","year":"2015","unstructured":"Giles DA, Moreno-Fernandez M, Divanovic S. IL-17 axis driven inflammation in non-alcoholic fatty liver disease progression. Curr Drug Targets. 2015;16:1315\u201323.","journal-title":"Curr Drug Targets."},{"key":"4200_CR41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.23792","volume":"52","author":"S Ferri","year":"2010","unstructured":"Ferri S, Longhi MS, De Molo C, Lalanne C, Muratori P, Granito A, et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology. 2010;52:999\u20131007.","journal-title":"Hepatology."},{"key":"4200_CR42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14:181\u201394.","journal-title":"Nat Rev Immunol"},{"key":"4200_CR43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/liv.12011","volume":"33","author":"A Hoh","year":"2013","unstructured":"Hoh A, Dewerth A, Vogt F, Wenz J, Baeuerle PA, Warmann SW, et al. The activity of \u03b3\u03b4 T cells against paediatric liver tumour cells and spheroids in cell culture. Liver Int. 2013;33:127\u201336.","journal-title":"Liver Int."},{"key":"4200_CR44","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/eji.201646407","volume":"46","author":"TB Buus","year":"2016","unstructured":"Buus TB, Geisler C, Lauritsen JP. The major diversification of V\u03b311+ and V\u03b32+ thymocytes in mice occurs after commitment to the \u03b3\u03b4 T cell lineage. Eur J Immunol. 2016;46:2363\u201375.","journal-title":"Eur J Immunol."},{"key":"4200_CR45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-065X.2006.00478.x","volume":"215","author":"N Xiong","year":"2007","unstructured":"Xiong N, Raulet DH. Development and selection of \u03b3\u03b4 T cells. Immunol Rev. 2007;215:15\u201331.","journal-title":"Immunol Rev."},{"key":"4200_CR46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF03401834","volume":"7","author":"C Agrati","year":"2001","unstructured":"Agrati C, D\u2019Offizi G, Narciso P, Abrignani S, Ippolito G, Colizzi V, et al. V\u03b41T lymphocytes expressing a Th1 phenotype are the major \u03b3\u03b4 T cell subset infiltrating the liver of HCV-infected persons. Mol Med. 2001;7:11\u20139.","journal-title":"Mol Med."},{"key":"4200_CR47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1084\/jem.20030584","volume":"198","author":"Y Gao","year":"2003","unstructured":"Gao Y, Yang W, Pan M, Scully E, Girardi M, Augenlicht LH, et al. \u03b3\u03b4 T cells provide an early source of interferon \u03b3 in tumor immunity. J Exp Med. 2003;198:433\u201342.","journal-title":"J Exp Med."},{"key":"4200_CR48","doi-asserted-by":"crossref","first-page":"e1005367","DOI":"10.1371\/journal.ppat.1005367","volume":"12","author":"X Wang","year":"2016","unstructured":"Wang X, Ma K, Chen M, Ko KH, Zheng BJ, Lu L. IL-17A promotes pulmonary B-1a cell differentiation via induction of Blimp-1 expression during influenza virus infection. PLoS Pathog. 2016;12:e1005367.","journal-title":"PLoS Pathog."},{"key":"4200_CR49","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/hep.28644","volume":"64","author":"W Seo","year":"2016","unstructured":"Seo W, Eun HS, Kim SY, Yi HS, Lee YS, Park SH, et al. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by \u03b3\u03b4 T cells in liver fibrosis. Hepatology. 2016;64:616\u201331.","journal-title":"Hepatology."},{"key":"4200_CR50","doi-asserted-by":"crossref","first-page":"e1006957","DOI":"10.1371\/journal.ppat.1006957","volume":"14","author":"X He","year":"2018","unstructured":"He X, Xie J, Wang Y, Fan X, Su Q, Sun Y, et al. Down-regulation of microRNA-203-3p initiates type 2 pathology during schistosome infection via elevation of interleukin-33. PLoS Pathog. 2018;14:e1006957.","journal-title":"PLoS Pathog."},{"key":"4200_CR51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"AM Gressner","year":"2006","unstructured":"Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76\u201399.","journal-title":"J Cell Mol Med."},{"key":"4200_CR52","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0016-5085(94)90126-0","volume":"107","author":"TF Kresina","year":"1994","unstructured":"Kresina TF, He Q, Degli Esposti S, Zern MA. Gene expression of transforming growth factor beta 1 and extracellular matrix proteins in murine Schistosoma mansoni infection. Gastroenterology. 1994;107:773\u201380.","journal-title":"Gastroenterology."},{"key":"4200_CR53","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1053\/j.gastro.2008.06.032","volume":"135","author":"LA Haile","year":"2008","unstructured":"Haile LA, von Wasielewski R, Gamrekelashvili J, Kr\u00fcger C, Bachmann O, Westendorf AM, et al. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology. 2008;135:871\u201381.","journal-title":"Gastroenterology."},{"key":"4200_CR54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol. 2016;37:208\u201320.","journal-title":"Trends Immunol."},{"key":"4200_CR55","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3389\/fimmu.2019.00893","volume":"10","author":"CJ Weston","year":"2019","unstructured":"Weston CJ, Zimmermann HW, Adams DH. The role of myeloid-derived cells in the progression of liver disease. Front Immunol. 2019;10:893.","journal-title":"Front Immunol."},{"key":"4200_CR56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2014.11.009","volume":"27","author":"MR Rutkowski","year":"2015","unstructured":"Rutkowski MR, Stephen TL, Svoronos N, Allegrezza MJ, Tesone AJ, Perales-Puchalt A, et al. Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. Cancer Cell. 2015;27:27\u201340.","journal-title":"Cancer Cell."},{"key":"4200_CR57","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2174\/0929866522666150520145554","volume":"22","author":"J Krstic","year":"2015","unstructured":"Krstic J, Obradovic H, Kukolj T, Slavko M, Ivana OD, Diana B, et al. An overview of interleukin-17A and interleukin-17 receptor a structure, interaction and signaling. Protein Pept Lett. 2015;22:570\u20138.","journal-title":"Protein Pept Lett."},{"key":"4200_CR58","doi-asserted-by":"crossref","first-page":"5103672","DOI":"10.1155\/2018\/5103672","volume":"2018","author":"K Ramani","year":"2018","unstructured":"Ramani K, Tan RJ, Zhou D, Coleman BM, Jawale CV, Liu Y, et al. IL-17 receptor signaling negatively regulates the development of tubulointerstitial fibrosis in the kidney. Mediators Inflamm. 2018;2018:5103672.","journal-title":"Mediators Inflamm."},{"key":"4200_CR59","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1152\/ajplung.00301.2016","volume":"312","author":"H Yanagisawa","year":"2017","unstructured":"Yanagisawa H, Hashimoto M, Minagawa S, Takasaka N, Ma R, Moermans C, et al. Role of IL-17A in murine models of COPD airway disease. Am J Physiol Lung Cell Mol Physiol. 2017;312:122\u201330.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"4200_CR60","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/path.4956","volume":"243","author":"A Lebrun","year":"2017","unstructured":"Lebrun A, Lo Re S, Chantry M, Izquierdo Carerra X, Uwambayinema F, Ricci D, et al. CCR2 monocytic myeloid-derived suppressor cells (M-MDSCs) inhibit collagen degradation and promote lung fibrosis by producing transforming growth factor-\u03b21. J Pathol. 2017;243:320\u201330.","journal-title":"J Pathol."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-04200-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-020-04200-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-04200-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T07:39:53Z","timestamp":1696318793000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-020-04200-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4200"],"URL":"https:\/\/doi.org\/10.1186\/s13071-020-04200-4","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]},"assertion":[{"value":"13 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals of the Ministry of Science and Technology, China. The protocol was approved by the Laboratory Animals Welfare and Ethics Committee of the National Institute of Parasitic Diseases, Chinese Center for Diseases Control and Prevention (Permit Number: NIPD-2017001). All the animal carcasses were disposed of by the Shanghai Animal Harmless Treatment Center. A special effort was made to reduce the number of mice used in the study, to provide them with the most comfortable conditions possible, and to minimize animal suffering where possible.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"334"}}